The GluA2 (GluR2) subunit is critical for the regulation of AMPA receptor properties and synaptic plasticity, but the underlying mechanisms remain unclear. Here, we demonstrate that GluA2 regulates metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) through a previously unknown mechanism involving N-cadherin-dependent and cofilin-mediated actin reorganization. We show that GluA2 is indispensable for mGluR-LTD in the hippocampus, and surprisingly this action of GluA2 is mediated by its extracellular domain interaction with N-cadherin. Accordingly, we show that the function of N-cadherin is regulated by and required for mGluR-LTD. Furthermore, we show that the regulatory effect of GluA2/N-cadherin is mediated through activation of Rho GTPase Rac1 and its downstream actin regulator cofilin, and, importantly, the requirement for GluA2/N-cadherin can be overcome by manipulating cofilin. These results provide compelling evidence that the extracellular domain of GluA2 regulates long-lasting synaptic plasticity through a signaling mechanism that is distinct from those used by the other domains of the receptor subunit.
Introduction
AMPA subtype glutamate receptors (AMPARs) are the principle mediators of fast excitatory synaptic transmission and are important for the expression of various forms of long-lasting synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD), widely studied cellular models for learning and memory (Malenka and Bear, 2004; Lüscher and Huber, 2010) . In hippocampal CA1 pyramidal neurons, most AMPARs are heteromeric complexes assembled from GluA1 and GluA2 (also referred to as GluR1 and GluR2) (Hollmann and Heinemann, 1994; Collingridge et al., 2009; Lu et al., 2009) . The GluA2 subunit is particularly interesting because it determines a number of important properties of AMPARs, including Ca 2ϩ permeability, single-channel conductance, and receptor trafficking at the synapse (Isaac et al., 2007) . The role of GluA2 in AMPAR trafficking has attracted special attention because it provides a key mechanism for regulating the number of synaptic receptors and plasticity (Malinow and Malenka, 2002; Bredt and Nicoll, 2003; Collingridge et al., 2004; Shepherd and Huganir, 2007; Kerchner and Nicoll, 2008) . Thus, genetic disruptions of GluA2 function have been shown to cause dramatic changes in AMPAR functionality and synaptic properties (Jia et al., 1996; Gerlai et al., 1998; Yan et al., 2002; Shimshek et al., 2006a,b; Panicker et al., 2008) .
The exact mechanisms by which GluA2 regulates AMPAR trafficking and synaptic plasticity are not clear. However, it is known that GluA2, via its N-terminal domain (NTD), transmembrane domain (TM), and C-terminal domain (CTD), can interact with several subunit-and domain-specific proteins, and it is thought through these specific interactions that GluA2 exerts its unique regulatory effects on AMPAR properties (Isaac et al., 2007) . In particular, GluA2 CTD protein interactions with protein interacting with C kinase-1 (PICK1), N-ethylmaleimidesensitive factor (NSF), and AMPAR-binding protein (ABP)/ glutamate receptor interacting protein (GRIP) have attracted the most attention because of their demonstrated importance in regulating AMPAR internalization and the expression of several forms of LTD (Isaac et al., 2007; Lüscher and Huber, 2010) . The GluA2 NTD is known to interact with the cell adhesion molecule N-cadherin to regulate spine properties, but the functional significance of this interaction in synaptic plasticity remains unknown (Passafaro et al., 2003; Saglietti et al., 2007) .
In this study, we investigated the role and underlying mechanisms of the NTD of GluA2 in the regulation of synaptic plasticity at hippocampal CA1 synapses. We show that the GluA2 NTD/N-cadherin interaction is critically required for metabotropic glutamate receptor-dependent LTD (mGluR-LTD), and that this action is mediated by cofilin-dependent actin reorganization. Thus, regulation of actin-based process by the GluA2/Ncadherin interaction provides an additional mechanism by which AMPARs regulate long-lasting synaptic plasticity at the central synapse.
Materials and Methods
GluA2 and LIM kinase-1 knock-out mice. The generation and initial characterization of GluA2 knock-out (KO), GluA3 KO, and LIM kinase-1 (LIMK-1) KO mice were described previously (Jia et al., 1996; Meng et al., 2002 Meng et al., , 2003 . To generate LIMK-1/GluA2 double KO mice, we crossed GluA2 ϩ/Ϫ with LIMK-1 ϩ/Ϫ to obtain the double heterozygotes GluA2
, which were subsequently interbred to yield GluA2 Ϫ/Ϫ /LIMK-1 Ϫ/Ϫ double KO mice. The double KO mice were viable and showed a similar phenotype as the GluA2 KO mice in growth, viability, and home-cage behavior. Whenever possible, the investigators were blind to the mouse genotypes used for the experiments.
Electrophysiology. The mouse brains from various genotypes were quickly removed and sagittal 300 -400 m hippocampal slices prepared in ice-cold artificial CSF (ACSF) saturated with 95% O 2 /5% CO 2 . ACSF contained the following (in mM): 120 NaCl, 3.0 KCl, 1.2 MgSO 4 , 1.0 NaH 2 PO 4 , 26 NaHCO 3 , 2.0 CaCl 2 , and 11 D-glucose. The slices were recovered at room temperature for at least 2 h before a single slice was transferred to a submersion chamber perfused with 95% O 2 /5% CO 2 saturated ACSF with (for whole-cell recordings) or without (for field recordings) 100 M picrotoxin. Hippocampal CA1 neurons were visualized using an infrared differential interference contrast microscope (Axioscope 2, Zeiss). Synaptic transmission was evoked by stimulation (at 0.05 Hz for field recordings or 0.1 Hz for whole-cell recordings) of Schaffer collaterals and was recorded with glass pipettes (3-4 M⍀) filled with either ACSF (for field responses) or with an intracellular solution (for whole-cell response) containing the following (in mM): 130 CsMeSO 4 , 5 NaCl, 1 MgCl 2, 0.05 EGTA, 10 HEPES, 3 Mg-ATP, 0.3 Na 3 GTP, and 5 QX-314, pH 7.25 (280 -300 mOsm). Two protocols were used to induce mGluR-LTD: bath application of 100 M (RS)-3.5-DHPG (3,5-dihydroxyphenylglycine) (DHPG-induced LTD) for 10 min or pairedpulse low-frequency stimulation consisting of 900 pairs of stimuli with 50 ms interstimulus interval delivered at 1 Hz (PP-LFS-induced LTD) in the presence of 100 M NMDA receptor antagonist DL-APV. LTD was calculated and statistically evaluated by comparing the mean values of the last 10 min of the recording and the mean values of the entire baseline. Whole-cell series resistance was monitored throughout LTD experiments by applying a Ϫ3 mV step at the end of each response, and depending on whether it changed by Ͼ20% the experiment was excluded from analysis. For whole-cell mGluR-LTD experiments, cells were clamped at Ϫ65 mV throughout the experiment. For peptide and antibody infusion experiments, the lack of the effect of each drug on basal synaptic responses was independently tested by conducting baseline recordings in the presence of the drug for at least 1 h without LTD induction. For current/voltage (I/V) relation and rectification index experiments, AMPAR EPSCs (10 responses) were recorded at various holding potential (Ϫ80, Ϫ60, Ϫ40, Ϫ20, 0, ϩ20, ϩ40, and ϩ60 mV) with the above intracellular solution plus 100 M spermine and the extracellular ACSF containing 100 M DL-APV. EPSC amplitudes were normalized to those recorded at Ϫ60 mV. Rectification indices were calculated by the ratios of EPSC amplitude at ϩ40/Ϫ60 mV. For whole-cell recordings of cultured hippocampal neurons, the cells were washed and perfused with extracellular fluid (ECF) containing the following (in mM): 120 NaCl, 1.2 MgCl 2 , 3.0 KCl, 2.0 CaCl 2 , 25 HEPES, 25 D-glucose, 0.0005 tetrodotoxin, and 0.05 picrotoxin, pH 7.35 280 -300 mOsm), and recorded under the same condition as for the acute hippocampal slices. mGluR-LTD in cultured neurons was induced by bath application of 100 M DHPG for 5 min and recorded at Ϫ65 mV holding potential. All data acquisition and analysis were done using pCLAMP 8 (Molecular Devices) and MiniAnalysis program (Synaptosoft). When average data were plotted, data were normalized to the average of the baseline responses unless indicated otherwise. In all electrophysiological experiments, n represents the number of neurons or slices, and normally only one or two slices or neurons per animal were used.
Neuronal culture, immunostaining, and image analysis. Hippocampal neuronal cultures were prepared from postnatal day 1 (P1) pups as previously described (Meng et al., 2002) . Briefly, pups were killed and hippocampal CA1 regions were dissected in ice-cold PBS. Tissues were trypsinized (0.25%) at 37°C for 15 min, dissociated by trituration, and plated onto poly-D-lysine (50 g/ml) coated glass coverslips (60,000 cells/ml for immunostaining experiments and 90,000 cells/ml for electrophysiological experiments). The cultures were maintained by replacing half of the medium with fresh medium every 3-5 d. The maintenance medium contained Neurobasal A, 0.5 mM GlutaMax, B27 and 5 ng/ml ␤-FGF. Whenever possible, the KO cultures were prepared together along with the WT littermates on the same 24-well plates for better comparison. For immunostaining (17-18 DIV), culture medium was replaced with ECF and treated with 100 M DHPG for 5 min (same procedure used for electrophysiology in cultured neurons). Immediately following the treatment cells were then fixed with ice-cold 4% paraformaldehyde ϩ 4% sucrose for 20 min and permeabilized (except for GluA1 surface staining) with 0.25% Triton X-100 for additional 20 min. Cells were then blocked with 3% donkey serum and 3% BSA in PBS for 1 h, incubated with primary antibodies overnight at 4°C followed by rhodamine-conjugated phalloidin and appropriate secondary antibodies (Invitrogen, Jackson ImmunoResearch) for 1 h at room temperature. After washing with PBS, coverslips were mounted using DAKO mounting medium for image collections. The primary antibodies used included: antiGluA1 (Calbiochem), anti-Synapsin I (Santa Cruz Biotechnology), anti-MAP2 (microtubule-associated protein 2) (Millipore), anti-cofilin (Cytoskeleton), anti-␤-catenin (Cell Signaling Technology), and anti-PSD95 (Millipore). Confocal images were obtained on a Zeiss LSM 510 laser scanning system at 2048 ϫ 2048 pixels using a Zeiss 63ϫ (numerical aperture, 1.4) objective with the same settings and configurations within each experiment. Spines were defined as any dendritic protrusions 0.3-4 m in length. The spine length was measured from the base of the spine (defined with MAP2 staining) to the tip of the spine head. For analysis of synaptic proteins, the fluorescence puncta (with an area of Ͼ0.1 m 2 ) were automatically selected and counted, and manually verified. For each genotype or treatment, ϳ20 -35 neurons from at least three independent cultures and a total of 100 -150 m linear dendrites per neuron were randomly selected, measured, and averaged. All measurements were performed using ImageJ (National Institutes of Health) and Volocity 5.2 (Improvision) software.
Slice treatment and biochemical assays. Hippocampal slices used for immunoprecipitation and Western immunoblotting experiments were prepared according to the same procedure as for electrophysiological recordings. Slices were recovered for 3-4 h at room temperature in ACSF saturated with 95% O 2 /5%CO 2 and transferred to a treatment chamber for additional 30 min recovery before DHPG treatment. The treatment was initiated by applying 100 M DHPG for 5 min. Some slices were removed immediately before DHPG application (0 min) and used as untreated controls. For the INP peptide preincubation, 50 M INP or equivalent DMSO vehicle was added during the 30 min recovery period in the treatment chamber. At the end of DHPG treatment, slices were rapidly frozen in dry ice/ethanol slurry and stored at Ϫ20°C. To prepare protein lysate, slices samples were lysed for 45 min in ice-cold cell lysis buffer containing the following (in mM): 20 Tris pH 7.5, 150 NaCl, 1 EDTA, 1 EGTA, 1% Triton X-100, 2.5 sodium pyrophosphate, 1 ␤-glycerophosphate, 1 Na 3 VO 4 , 20 NaF, 1 g/ml leupeptin, 1 phenylmethylsulfonyl fluoride, and 0.5% protease inhibitor mixture (Calbiochem). Debris was removed by centrifugation at 12,000 rpm (4°C) for 10 min. The total protein concentration of each sample was estimated using BCA assay (GE Healthcare) and equalized with loading buffer. Proteins were separated on 10% SDS-PAGE polyacrylamide gel and electrotransferred to a nitrocellulose filter. Filters were then blocked with 2.5% dry milk/2.5% normal fetal bovine serum in TBS-T (20 mM Tris base, 9% NaCl, 0.1% Tween-20, pH 7.6) and incubated overnight at 4°C with appropriate primary antibodies in TBS-T. Following washing and incubation with appropriate secondary antibodies, filters were developed using enhanced chemiluminescence (GE Healthcare) method of detection and analyzed using the AlphaEaseFC software as per manufacturer's instruction. Protein loading was further controlled by normalizing each tested protein with tubulin immunoreactivity on the same blot. For immunoprecipitation experiments, 300 l of the protein lysate (200 -300 g, normally pooled from two to three hippocampal slices) was incubated with appropriate primary antibodies at 4°C with constant gentle rocking for 3-5 h followed by the addition of 35 l of protein A (for rabbit antibodies) or G (for mouse antibodies) agarose bead slurry (Santa Cruz Biotechnology) and further incubation of 3 h at 4°C. The samples were microcentrifuged for 1 min at 12,000 rpm, the supernatant was carefully removed, and the beads were washed thoroughly five times with the lysis buffer and resuspended in loading buffer for Western blot analysis. For Rac1 (Ras-related C3 botulinum toxin substrate 1)/RhoA (Ras homolog gene family, member A) activation assay, a procedure recommended by the manufacturer (Biochem Kit, Cytoskeleton) was followed. Primary antibodies used included the following: anticofilin and anti-Rac1 (Cytoskeleton), anti-pCofilin (Santa Cruz Biotechnology), anti-ERK1/2 (extracellular signal-regulated kinase 1/2), anti-pERK1/2, anti-N-cadherin, anti-␤-catenin, and anti-pTyrosine (Cell Signaling Technology). n in the summary data represents the number of independent experiments. Viral vector construction, virus purification, and in vivo injection. The basic principles for using helper phage-dependent adenovirus-based vectors have been described previously (Sandig et al., 2000) . We used the shuttle vector pC4HSU because much of its genomic sequence can be replaced by foreign DNA (e.g., GluA2 cDNA) without perturbing virus packaging as long as the resultant construct size ranges from 27 to 38 kb. To make GluA2 viral vectors, various forms of GluA2 cDNA and enhanced green fluorescent protein (EGFP) were first subcloned respectively into unique restriction sites XhoI and SpeI of an intermediate vector modified from k18EpiSEAP. Both GluA2 and EGFP cassettes contained their own human CMV (cytomegalovirus) immediate early promoter and SV40 (simian virus 40) early mRNA polyA (polyadenylation) signal; therefore, they were transcribed and translated independently as two separate proteins. The cDNAs of GluA2 used included the following: wild-type (WT) hemagglutinin (HA)-tagged full-length GluA2, HAtagged GluA2 ⌬92, Myc-tagged GluA1-NTD87-GluA2, and Myc-tagged GluA2-NTD92-GluA1. The pC4HSU vector was then cut with AscI and NotI, blunted, and relegated to remove a 4.5 kb fragment to harbor the GluA2/EGFP cassettes. And finally, the GluA2/EGFP was released from the modified k18EpiSEAP vector with MluI and inserted into the unique MluI site of pC4HSU. The total size of the final viral constructs used in this study ranged from 30 to 35 kb.
To make a large-scale virus preparation, 15 g of viral construct DNA was linearized by PmeI digestion to remove the plasmid backbone, and the viral DNA fragment (10 g) was purified and transfected into the Cre-expressing packaging cell line 293Cre66 using standard calcium phosphate method at 75% confluency (CellPhect Transfection Kit, GE Healthcare). 293Cre66 cells were cultured in full growth medium containing Eagle's minimal essential medium (MEM), 10% FBS, 50 g/ml hygromycin B (Roche), and 1ϫ antibiotic-antimycotic (Wisent). Helper virus NG163 was added to the culture medium 12 h after transfection, and when cytopathic effect (CPE; cells became rounded and detached from the plate) occurred (usually between 48 and 72 h postinfection), cells and medium [crude viral lysate (CVL)] were transferred to a cryotube and rapidly frozen in dry ice-ethanol mixture. Twenty percent of the collected CVL was then used to infect fresh 293Cre66 cells (with the NG163 helper virus added 12 h later to induce CPE), and CVL was collected for the subsequent infection cycle. The cycle was repeated three more times to accumulate a sufficient amount of CVL for final virus production, where a spinner suspension culture system containing 3 L of calcium-free Joklik MEM (Sigma-Aldrich) was used to prevent cell aggregation.
To harvest the viral particles, cells in suspension culture were collected by centrifugation at 2000 rpm, 4°C for 10 min, resuspended in 15 ml of dilution buffer (10 mM Tris-Cl, pH 8.0), and stored at Ϫ80°C for later purification. To purify the virus, cells were lysed through multiple freezing/thawing cycles (freezing in a dry ice/ethanol bath and thawing at 37°C) followed by incubation in the detergent sodium deoxycholate (0.5%) for 30 min at room temperature with occasional shaking. The lysate was then treated with 1000 units of Benzonase Nuclease (SigmaAldrich) for 20 min to reduce viscosity, and the debris was removed by centrifugation for 10 min at 5000 ϫ g and 4°C. The clear supernatant containing the viral particles were then further purified by two cycles of ultracentrifugation in CsCl density gradients. The first cycle density gradient was prepared in a thin-wall Ultra-Clear tube (catalog #344059, Beckman Coulter) containing 3 ml of low-density CsCl gradient solution (1.25 g/ml), 3 ml of medium-density CsCl gradient solution (1.35 g/ml), and 1 ml of high-density CsCl gradient solution (1.5 g/ml). Six milliliters of the viral supernatant was carefully overlaid on the top of the density gradient and centrifuged in a SW 41 Ti swinging bucket rotor for 1 h at 35,000 ϫ g and 4°C. The opalescent band at the interface between lowand medium-density CsCl gradients was then collected and subjected to the second cycle of ultracentrifugation (for 24 h at 35,000 ϫ g and 4°C) in a continuous medium-density gradient of CsCl (1.35 g/ml). Finally, the opalescent band containing the virus was recovered and dialyzed extensively in the dialysis buffer containing 10 mM Tris-Cl, pH 8.0, and 1 mM MgCl 2 (Slide-A-Lyzer cassette, Thermo Scientific Pierce). The viral stock was then stored in 10% glycerol at Ϫ80°C before injections.
For in vivo viral injections, we used a mixture of ketamine and xylazine (80 mg/10 mg, i.p.) for anesthesia. The animal was mounted on a stereotaxic apparatus. When both bregma and lambda were set at the same dorsoventral level, a midline incision was made with no. 15 surgical scalpels. Then the subcutaneous tissue was cleaned using small surgical forceps. Stereotaxic targeting was done by lowering a glass micropipette fixed to the stereotaxic holder. The coordinates for injecting dorsal hippocampal CA1 region were lateral 2.0 mm, ventral 1.4 mm, and caudal 2.1 mm. At the skull position with the above coordinates, a micro-drill with a 0.7 mm spinning drill bit was used to thin the skull until blood vessels in the dura became clearly visible. The thinned bone was then removed and cleaned with PBS. Glass micropipettes back-filled with viral solutions (1 ϫ 10 7 particles per microliter in 10 mM Tris-Cl) were slowly lowered to the desired z-coordinate of CA1. For one hippocampus, 1 l of the viral solution was gradually injected over a period of 20 min using a 10 l Hamilton syringe. Once the injection was completed, the wounds were sutured and cleaned, and mice were returned to their home cages. All the animal procedures used in this study were approved by the Hospital for Sick Children Animal Use Committee. All the averaged data in this study were reported as the mean Ϯ SEM and statistically evaluated by Student's t test. A p value Ͻ0.05 was considered to be significant and is indicated with the * symbol in the summary graphs in all figures.
Results

GluA2 is indispensable for mGluR-LTD in the hippocampus
At CA1 synapses, at least two forms of LTD coexist: NMDA receptor (NMDAR)-dependent LTD (NMDAR-LTD) and mGluRdependent LTD (mGluR-LTD) (Malenka and Bear, 2004; Lüscher and Huber, 2010) . Although GluA2 has been extensively investigated in the context of NMDAR-LTD (Isaac et al., 2007) , its role in mGluR-LTD remains unknown. We therefore focus this study on mGluR-LTD. We induced mGluR-LTD using two separate protocols: bath application of the group I mGluR agonist DHPG; or PP-LFS in the presence of NMDA receptor antagonist APV (Kemp and Bashir, 1999; Huber et al., 2000) . Since the expression mechanism of mGluR-LTD is subject to developmental regulation (Nosyreva and Huber, 2005) , we therefore focused our studies on young adults (7-9 weeks), at which time both the induction and expression mechanisms are dependent on postsynaptic changes and local protein synthesis (Huber et al., 2000; Nosyreva and Huber, 2005; Waung and Huber, 2009; Lüs-cher and Huber, 2010) . As shown in Figure 1A , the application of DHPG in both WT and GluA3 (GluR3) KO animals induced a decrease in field EPSPs (fEPSPs) that persisted during the entire recording period, but this DHPG-induced LTD was completely abolished in GluA2 KO mice (WT ϭ 77.03 Ϯ 1.83%; GluA3 KO ϭ 81.37 Ϯ 4.59%; GluA2 KO ϭ 109.71 Ϯ 5.98%; p Ͻ 0.001 between WT and GluA2 KO). Similarly, application of PP-LFS induced a persistent decrease in fEPSPs in both WT and GluA3 KO mice, but this PP-LFS-induced LTD was completely absent in GluA2 KO mice ( Fig. 1B: WT ϭ 77.89 Ϯ 3.20%; GluA3 KO ϭ 83.14 Ϯ 3.11%; GluA2 KO ϭ 109.21 Ϯ 4.86%; p Ͻ 0.001 between WT and GluA2 KO). The DHPG-induced LTD was blocked by the group I mGluR antagonist MPEP (supplemental Fig. 1A , available at www. jneurosci.org as supplemental material), confirming that this DHPG-induced LTD is mGluR-dependent. The DHPG-and PP-LFS-induced LTD was also completely abolished by the protein synthesis inhibitor cycloheximide ( Fig. 1C : control ϭ 84.42 Ϯ 3.43; cycloheximide ϭ 100.40 Ϯ 2.28; p Ͻ 0.001) ( Fig. 1D : control ϭ 77.30 Ϯ 4.75%; cycloheximide ϭ 105.14 Ϯ 2.62; p Ͻ 0.001), but without changes in the rectification index (supplemental Fig. 1 B, C, available at www.jneurosci.org as supplemental material) or activation of AMPARs (supplemental Fig. 1D , available at www.jneurosci. org as supplemental material). These results indicate that GluA2 is indispensable for mGluR-LTD at CA1 synapses.
One potential problem of the above experiments was that the LTD deficit in GluA2 KO mice might be related to the chronic effect caused by GluA2 deletion. To rule out this possibility, we developed helper phage-dependent adenoviral (HDAv) vectors expressing the EGFP alone or EGFP plus HA-tagged full-length GluA2 protein (A2ϩEGFP) and performed rescue experiments by injecting these viruses into the adult hippocampus of GluA2 KO mice. We chose this expression system because the vector can harbor a large amount of exogenous DNA sequences to allow the expression of multiple genes in a single construct (Barcia et al., 2007) . This was particularly important for this study because we preferred to express GluA2 and EGFP as two separate proteins (rather than a fusion protein) to avoid any perturbations of GluA2 function that might be caused by the fusion (supplemental Fig. 1 E, available at www. jneurosci.org as supplemental material). Infection experiments using the viruses containing both GluA2 and EGFP in HEK 293 cells and cultured neurons showed that all EGFP-positive cells express GluA2, indicating that EGFP is a reliable indicator for GluA2 protein expression (data not shown). Three to five days following hippocampal viral injections, slices were prepared and EPSCs were recorded from infected CA1 neurons. As expected, the expression of EGFP alone had no effect on either I/V relation (i.e., inward rectification of AMPAR-mediated synaptic response characteristic of GluA2-lacking AMPARs) ( Fig. 1 E, F ) or the impairment of DHPGinduced LTD (Fig. 1G) in GluA2 KO mice. However, the expression of A2ϩEGFP completely rescued the rectification (Fig. 1 E, F : EGFP ϭ 0.22 Ϯ 0.05; A2ϩEGFP ϭ 0.53 Ϯ 0.03; p Ͻ 0.001), indicating that the exogenously expressed GluA2 was functional at the synapse. Importantly, DHPG-induced LTD was also completely restored in neurons expressing A2ϩEGFP (EGFP ϭ 111.15 Ϯ 5.54%; A2ϩEGFP ϭ 79.76 Ϯ 7.00%; p Ͻ 0.01). The expression of A2ϩEGFP had no effect on basal synaptic response, DHPG-induced LTD, or I/V relation in WT neurons (supplemental Fig. 1 F-H , available at www.jneurosci.org as supplemental material). These results confirmed that the absence of mGluR-LTD is not due to developmental effects of GluA2 ablation and that GluA2 is directly involved in the regulation of the mGluR-LTD process.
GluA2 NTD interaction with N-cadherin is necessary for GluA2 to regulate hippocampal mGluR-LTD
The above results indicate that GluR2 is indispensable for mGluR-LTD expression. Since GluR2 CTD-dependent endocytosis of AMPARs is considered to be the key mechanism underlying several forms of LTD (e.g., cerebellar LTD and hippocampal NMDAR-LTD) (Malinow and Malenka, 2002; Collingridge et al., 2004; Isaac et al., 2007) , then it is possible that the impaired mGluR-LTD in GluA2 KO mice is simply due to the lack of the GluA2 CTD-dependent processes. However, this interpretation may not apply in this case. It has been proposed that the role of the GluA2 CTD in activity-dependent AMPAR internalization is to release AMPARs from anchor proteins (e.g., GRIP/ABP). In neurons lacking GluA2 (i.e. GluR2 KO mice and some interneurons), AMPARs exist without being anchored by GRIP/ ABP, and therefore, they are free to enter the endocytic process upon LTD induction (Brown et al., 2005) . This may explain why GluR2 KO mice still show robust NMDAR-dependent LTD and NMDA-induced AMPAR internalization (Jia et al., 1996; Meng et al., 2003; Biou et al., 2008) . Therefore, we reasoned that the lack of GluA2 CTD-dependent endocytosis is not likely to account for the impaired mGluR-LTD in GluA2 KO mice. To test this possibility and determine which domain of GluA2 is important for mGluR-LTD, we performed additional in vivo viral rescue experiments by using various GluA2 mutant constructs. We first examined the effects of expressing a deletion mutant GluA2, A2-⌬92, where the first 92 aa of GluA2 NTD were removed, and thus were no longer able to bind to N-cadherin, but still retained all other key unique properties of GluA2, including its TM/CTD protein interactions [i.e., with TARPs (transmembrane AMPAR regulatory proteins), PICK1, NSF, and ABP/ GRIP) and channel rectification properties (Saglietti et al., 2007) . As shown in Figure 2 , although this mutant construct was able to restore the linear I/V relation of AMPAR-mediated currents (Fig.  2 A, B: A2-⌬92 RI ϭ 0.62 Ϯ 0.05), confirming that it was functionally expressed at the synapse, it did not rescue mGluR-LTD in GluA2 KO mice (Fig. 2C ,E: A2-⌬92 ϭ 108.58 Ϯ 6.95%). This result was extremely intriguing to us because it suggests that the GluA2-CTD is not sufficient for mGluR-LTD regulation and that the GluA2 NTD interaction with N-cadherin is required. To fur- ther confirm the importance of the GluA2 NTD interaction, we examined the effect of expressing another mutant GluA2, A1-87-A2, a chimeric construct where the NTD 92 aa of GluA2 were replaced with the corresponding 87 aa of GluA1 to avoid deletions of any potentially important amino acids. The expression of this construct had a similar effect on GluA2 KO neurons (i.e., it restored the linear I/V relation) (Fig. 2 A, B: A1-87-A2 RI ϭ 0.67 Ϯ 0.17) but did not rescue the mGluR-LTD deficit (Fig. 2C ,E: A1-87-A2 ϭ 116.46 Ϯ 3.05%). Finally, to determine whether the GluA2 NTD/N-cadherin interaction was sufficient for mGluR-LTD rescue, we tested the effect of expressing A2-92-A1, where the entire GluA2 sequence except for the NTD 92 aa, was replaced by the corresponding GluA1 sequence. This chimeric construct is still able to interact with N-cadherin but lacks all the other properties of GluA2, including its TM/ CTD protein interactions, Ca 2ϩ impermeability, and channel rectification. The expression of this construct did not restore the linear I/V relation or rectification index (Fig. 2 A, B: A2-92-A1 RI ϭ 0.27 Ϯ 0.07), but remarkably, it completely restored mGluR-LTD (Fig.  2 D , E: A2-92-A1 ϭ 82.09 Ϯ 4.46%). In fact, the magnitude of DHPG-induced LTD in GluA2 KO neurons infected by A2-92-A1 was indistinguishable from that of GluA2 KO neurons infected by wild-type full-length GluA2 (i.e., A2ϩEGFP) or that of WT neurons infected by EGFP alone (Fig. 2E) . Together, these results confirm that the GluA2 NTD interaction with N-cadherin is both necessary and sufficient for GluA2 to rescue the mGluR-LTD deficit in GluA2 KO mice, indicating a critical importance for GluA2 NTD/N-cadherin interaction in mGluR-LTD regulation.
N-cadherin/catenin complex is regulated by mGluR activation and required for hippocampal mGluR LTD
Having identified the N-cadherin-binding motif on the GluA2 NTD as an essential mediator of GluA2 action in mGluR-LTD, we next examined whether N-cadherin signaling complex was also required for this form of plasticity. Earlier studies have shown that N-cadherins and their cytoplasmic partner catenins play an important role in synaptogenesis, spine structure, and LTP (Takeichi, 2007; Arikkath and Reichardt, 2008; Tai et al., 2008) , but their role in mGluR-LTD has not been tested. Interestingly, the integrity and function of the N-cadherin/catenin signaling complex is critically regulated by tyrosine phosphorylation/dephosphorylation (Lilien and Balsamo, 2005) , a process that is also critical for mGluR-LTD (Huang and Hsu, 2006; Moult et al., 2006; Zhang et al., 2008; Gladding et al., 2009 ). Therefore, we reasoned that the N-cadherin/catenin complex might be an essential signaling component for mGluR-LTD. To test this possibility, we performed the following experiments. First, we showed that the disruption of the N-cadherin/catenin complex abolished mGluR-LTD. We pretreated the hippocampal slices for 30 min with the short peptide INP (INPISGQ) or its reverse control peptide PNI (QGSIPNI) and then recorded DHPGinduced LTD in the presence of these peptides throughout the experiment. This INP peptide is mimetic of the extracellular ectodomain 1 on N-cadherin and has been shown to exert a highly specific and potent disruptive effect on N-cadherin function (Williams et al., 2000; Siu et al., 2007) . As shown in Figure  3A , the peptide-treated slices did not show any appreciable amount of DHPG-induced LTD, whereas the control (PNItreated) had a normal level of LTD (PNI ϭ 74.20 4.01%; INP ϭ 102.63 2.17%; p Ͻ 0.05). Neither INP nor PNI peptides had an effect in GluA2 KO mice (Fig. 3B) . fEPSP recordings generated similar results (supplemental Fig. 2 A, available at www.jneurosci. org as supplemental material). Application of INP peptide for up to 1 h without DHPG treatment did not have any effects on basal synaptic responses, indicating that INP treatment alone is not sufficient to induce any synaptic plasticity (supplemental Fig. 2 B, available at www.jneurosci.org as supplemental material). Application of INP peptide after DHPG treatment also had no effect on DHPG-induced LTD (supplemental Fig. 2C , available at www. jneurosci.org as supplemental material). These results indicated that intact N-cadherin/catenin function is likely required for the induction phase of mGluR-LTD. Second, we performed immunoprecipitation experiments to show that DHPG was able to induce functional changes in N-cadherin/catenin complex, which was occluded by the INP peptide pretreatment. Hippocampal slices were prepared and treated with various drugs in a similar manner as for LTD recordings, but following the treatment the slices were rapidly frozen and the protein lysate was extracted for analysis of ␤-catenin, a major cytoplasmic binding partner and reliable functional indicator for N-cadherin. In WT slices pretreated with the control PNI peptide, DHPG treatment significantly reduced N-cadherin/␤-catenin binding [ . Finally, we demonstrated that DHPGinduced reduction in N-cadherin/␤-catenin interaction required GluA2. As shown in Figure 3D , in GluA2 KO mice, the basal level of N-cadherin/␤-catenin binding was significantly lower and DHPG treatment instead induced an increase in this binding [GluA2 KO (0 min) ϭ 0.63 Ϯ 0.10, p Ͻ 0.01 compared with the WT (0 min) time point; GluA2 KO/DHPG (5 min) ϭ 1.36 Ϯ 0.22, GluA2 KO/DHPG (30 min) ϭ 1.20 Ϯ 0.09, p Ͻ 0.001 compared with the WT/DHPG (5 min)]. As a further support for GluA2 requirement in N-cadherin/ ␤-catenin signaling, we showed that both basal level and DHPGinduced increases in tyrosine-phosphorylated ␤-catenin, another important indicator of N-cadherin function, were also significantly altered in GluA2 KO mice (supplemental Fig. 2D ,E, available at www.jneurosci.org as supplemental material). These results together indicate the following: (1) mGluR activation induces functional changes in the N-cadherin/␤-catenin complex and these changes are necessary for DHPG-induced LTD; and (2) GluA2 is indispensable for the N-cadherin/␤-catenin complex to perform this function. These results are consistent with the idea that GluA2 regulates mGluR-LTD through interacting with the N-cadherin/catenin complex.
Hippocampal mGluR-LTD requires cofilin-mediated actin reorganization
How then does the GluA2/N-cadherin interaction regulate mGluR-LTD? Given the prominent role of N-cadherin signaling in actin regulation (Fukata and Kaibuchi, 2001; Bamji, 2005) , we reasoned that that GluA2/N-cadherin might regulate mGluR-LTD through actin reorganization. Indeed, application of F-actin perturbation agents has been shown to invariably block mGluR-LTD, but not NMDAR-LTD Zhou et al., 2004; Morishita et al., 2005; Moult et al., 2006) . To address this hypothesis, we set out to identify the molecular factors important for actin regulation during mGluR-LTD. First, we showed that actin reorganization in the postsynaptic neurons was necessary for mGluR-LTD. As shown in Figure 4 A, inclusion of the F-actin stabilizer phalloidin in the recording pipette to prevent F-actin depolymerization in the postsynaptic neuron completely blocked mGluR-LTD (control ϭ 67.66 Ϯ 4.71%; phalloidin ϭ 98.10 Ϯ 7.47%; p Ͻ 0.01). Surprisingly, inclusion of the actin polymerization inhibitor latrunculin A also blocked mGluR-LTD (Fig.  4 B: DMSO ϭ 70.01 Ϯ 5.80%; latrunculin ϭ 105.09 Ϯ 3.36%; p Ͻ 0.01). Neither phalloidin nor latrunculin A had any effect on NMDAR-dependent LTD or basal synaptic response (supplemental Fig. 3A ,B, available at www.jneurosci.org as supplemental material). These results indicated that both actin polymerization and depolymerization were required for DHPG-induced LTD. Since cofilin is a potent regulator of both processes (Bamburg, 1999; DesMarais et al., 2005) , we then tested whether mGluR-LTD also depended on cofilin. We used short inhibitory peptides (active peptide M and control peptide Q) known to specifically prevent cofilin from binding to F-actin, thus inhibiting cofilin activity (Eibert et al., 2004) . As shown in Figure 4C , the active peptide completely abolished DHPGinduced LTD, whereas the control peptide had no effect (M ϭ 99.67 Ϯ 4.83%; Q ϭ 68.20 Ϯ 7.21%; p Ͻ 0.005). To verify these results independently, we tested additional cofilin peptides, S3 and phospho-S3 (p-S3), which are known to enhance and block cofilin activity through inhibiting cofilin phosphorylation and dephosphorylation, respectively (Aizawa et al., 2001) . As shown in Figure 4 D, peptide p-S3 completely blocked DHPG-induced LTD, whereas peptide S3 had no effect (p-S3 ϭ 100.46 Ϯ 7.77%; S3 ϭ 72.44 Ϯ 4.40%; p Ͻ 0.01). Therefore, activation of cofilin through dephosphorylation is essential for DHPG-induced LTD. To identify the upstream regulators for cofilin, we tested the role of the Rho GTPases, direct substrates for N-cadherin/catenin complex and known to regulate cofilin activity (Bamburg, 1999; Fukata and Kaibuchi, 2001 ). Interestingly, we found that the Rac1 inhibitor (NSC23766) completely blocked DHPG-induced LTD (Fig. 4 E: control ϭ 73.96 Ϯ 2.41%; NSC23766 ϭ 101.03 Ϯ 5.64%; p Ͻ 0.01), whereas the RhoA inhibitor (C3 botulinum toxin) had no inhibitory effect (C3 toxin ϭ 54.63 Ϯ 5.33%, p Ͻ 0.05 compared with the control). In GluA2 KO neurons infected with A2-92-A1, DHPG-induced LTD was also blocked by cycloheximide, peptide p-S3 or Rac1 inhibitor (Figs. 2, 4F: cycloheximide ϭ 105.82 Ϯ 7.08%; pS3 ϭ 107.70 Ϯ 7.56%; NSC23766 ϭ 101.93 Ϯ 6.19%; p Ͻ 0.05 for each compared with GluA2 KO neurons infected with WT A2 or A2-92-A1), indicating that mGluR-LTD in GluA2 KO mice share similar mechanisms when GluA2 is introduced back to these mice. These results together provide strong evidence that regulation of cofilin by Rac1 GTPase is required for mGluR-LTD in the hippocampus.
GluA2/N-cadherin regulates hippocampal mGluR-LTD via cofilin
The above experiments indicated that both GluA2/N-cadherin and cofilin-mediated actin reorganization are necessary for mGluR-LTD, but the question remained whether these two processes are related. To test whether cofilin is a downstream target of GluA2/ N-cadherin, we performed two sets of experiments. First, we examined the effect of mGluR activation on Rac1/cofilin and showed that DHPG induced GluA2-dependent Rac1/cofilin activation. As shown in Figure 5 A, B, DHPG treatment induced rapid activation of both cofilin and Rac1 in WT slices (p-cofilin/ cofilin: 0.65 Ϯ 0.09, p Ͻ 0.05 compared with untreated; active Rac1/total Rac1: 1.50 Ϯ 0.19, p Ͻ 0.05 compared with untreated), and this activation was absent in GluA2 KO samples. In fact, there was small but significant inhibition of both cofilin and Rac1 by the treatment in the KO sample (Fig. 5 A, B) (p-cofilin/cofilin: untreated ϭ 0.96 Ϯ 0.04; treated ϭ 1.23 Ϯ 0.09; p Ͻ 0.05; active Rac1/total Rac1: untreated ϭ 1.02 Ϯ 0.04; treated ϭ 0.75 Ϯ 0.11; p ϭ 0.05). The DHPG-induced increase (compared with a decrease in WT) in both p-cofilin and N-cadherin/␤-catenin binding (Fig. 3D ) in GluA2 KO mice is of interest and suggests that a GluA2-independent, opposing signaling pathway targeting N-cadherin/␤-catenin and cofilin must be activated by DHPG treatment. It is possible that in the absence of GluA2, this opposing signaling pathway becomes dominant and leads to increased p-cofilin and N-cadherin/ ␤-catenin binding. In clear contrast to Rac1, DHPG treatment induced no changes in RhoA activity in both WT and GluA2 KO samples (Fig. 5C : WT DHPG treated ϭ 1.06 Ϯ 0.05; GluA2 KO untreated ϭ 0.98 Ϯ 0.19; GluA2 KO treated ϭ 1.02 Ϯ 0.15; p Ͼ 0.05 compared with WT untreated).
Consistent with previous studies (Gallagher et al., 2004; Mao et al., 2005) , we found that an inhibitor for the mitogenactivated protein kinase ERK1/2 (control ϭ 78.46 Ϯ 2.11%; PD98059 ϭ 103.14 Ϯ 3.64%; p Ͻ 0.001) but not for the p38 kinase (DMSO ϭ 82.55 Ϯ 2.38%; SB239063 ϭ 82.92 Ϯ 5.30%) prohibited DHPG-induced LTD (supplemental Fig. 4A , available at www.jneurosci.org as supplemental material). Accordingly, DHPG treatment induced a significant increase in the active form of ERK1/2 (phosphorylated ERK1/2) in WT (supplemental Fig. 4B , available at www.jneurosci.org as supplemental material) (DHPG ϭ 1.38 Ϯ 0.09, p Ͻ 0.01 compared with untreated), and this effect remained intact in GluA2 KO samples (DHPG ϭ 1.34 Ϯ 0.08, p Ͻ 0.05 compared with untreated). These experiments indicated that GluA2 is specifically required for mGluR-dependent Rac1/cofilin activation. Second, we showed that DHPG-induced cofilin activation was also dependent on proper N-cadherin function. Again, we pretreated the slices with the INP or PNI peptide and then examined DHPG-induced cofilin activation. As shown in Figure 5D It is important to note that INP-pretreated slices had a significantly lower level of phosphorylated cofilin under basal conditions before DHPG treatment, indicating that INP treatment was sufficient to induce cofilin activation. In addition, cofilin activation induced by the INP treatment observed in WT slices was absent in GluA2 KO samples (Fig.  5E ) (GluA2 KO/untreated ϭ 0.91 Ϯ 0.15; GluA2 KO/treated ϭ 0.82 Ϯ 0.04; p Ͼ 0.05). Since N-cadherin/catenin can also initiate signaling processes involving gene expression and protein synthesis, we tested whether DHPG-induced cofilin activation required these processes. As shown in supplemental Figure 4C (available at www.jneurosci.org as supplemental material), DHPGinduced cofilin dephosphorylation was not affected either by the transcription inhibitor actinomycin or protein synthesis inhibitor cycloheximide. These biochemical results are consistent with the idea that GluA2/N-cadherin regulates mGluR-LTD via protein synthesis-independent, cofilin-mediated actin dynamics. mGluR activation induces GluA2-dependent ␤-catenin and cofilin changes at the synaptic level in hippocampal neurons The above experiments on acute hippocampal slices have shown that GluA2/ N-cadherin/cofilin signaling is activated in and required for mGluR-LTD, but whether this signaling is activated at the synaptic level remains unknown. To address this issue, we extended our studies to cultured hippocampal neurons where synaptic properties can be better analyzed. First, we established DHPG-induced LTD in the culture system and showed that it shares the same mechanistic processes as in acute slices ( Fig. 6A; supplemental Fig.  5 , available at www.jneurosci.org as supplemental material). Consistent with previous studies (Snyder et al., 2001) , DHPG treatment caused a persistent decrease in the frequency (measured as increased interevent interval, 179.33 Ϯ 11.39% of basal level) (Fig. 6 A) , but not in the amplitude (97.11 Ϯ 4.37% of basal level) (supplemental Fig. 5A , available at www. jneurosci.org as supplemental material) of miniature EPSCs (mEPSCs). Importantly, DHPG-induced LTD in hippocampal slices was also associated with a decrease in the frequency in mEPSCs with minimal alterations in the amplitude (supplemental Fig.  5B , available at www.jneurosci.org as supplemental material). Similar to slices, DHPG-induced LTD in cultured neurons was dependent on GluA2 ( Fig. 6A: WT ϭ 179.33 Ϯ 11.39%; KO ϭ 115.21 Ϯ 14.68%; p Ͻ 0.001), protein synthesis, ERK signaling, Rac1 activation, actin dynamics, and cofilin (supplemental Fig. 5C -H, available at www.jneurosci.org as supplemental material). These experiments indicated that DHPG-induced LTD in cultured neurons employs the same mechanism as that of acute hippocampal slices.
Having established the in vitro system, we then examined DHPG-induced changes at the synapse by using the F-actin dye rhodamine phalloidin as a spine marker. F-actin is highly enriched in the dendritic spine and has been used widely as a useful indicator of spine and synaptic plasticity. First, we showed that DHPG-induced spine plasticity was dependent on GluA2. In WT neurons, DHPG treatment induced a significant increase in the mean spine length (Fig.  6B ,D: control ϭ 1.30 Ϯ 0.04 m; DHPG ϭ 1.90 Ϯ 0.07 m; p Ͻ 0.001) and a significant decrease in the spine density (Fig. 6B ,E: control ϭ 39.95 Ϯ 2.61; DHPG ϭ 30.34 Ϯ 2.30; p Ͻ 0.01). These results were similar to those previously reported (Vanderklish and Edelman, 2002) and were verified by using EGFP-infected neurons to visualize spines (data not shown). Because of spine elongation, the location of the presynaptic marker synaptophysin staining puncta in relation to the spine was altered; many synaptophysin puncta were found at the base of the spine after DHPG treatment as opposed to at the spine head in untreated neurons (Fig. 6C) . For easy analysis, we defined the spines with synapsin or synaptophysin puncta overlapping the spine head as synaptic or normal spines (although it should be stressed here that those elongated spines with synapsin/ synaptophysin puncta at the base or neck of the spine may still have functional synapses). Thus, DHPG treatment resulted in a significant reduction in normal spines (Fig.  6F : control ϭ 91.64 Ϯ 6.89%, DHPG ϭ 71.27 Ϯ 5.06%, p Ͻ 0.05; also see supplemental Fig. 6 , available at www.jneurosci. org as supplemental material). However, in GluA2 KO neurons, DHPG treatment had no effect on the spine length ( We next analyzed DHPG-induced cofilin changes in the dendritic spines. Under basal conditions, cofilin-staining puncta were partially colocalized with phalloidin puncta, indicating that only some cofilin was distributed in the spine. Following DHPG treatment, both the intensity of cofilin puncta (Fig. 6G ,H: control ϭ 1.00 Ϯ 0.06; DHPG ϭ 1.92 Ϯ 0.11; p Ͻ 0.001) and their colocalization with phalloidin (Fig. 6G,I : control ϭ 47.84 Ϯ 2.01%; DHPG ϭ 73.12 Ϯ 2.43%; p Ͻ 0.001) were significantly increased in WT neurons, but these changes were not observed in GluA2 KO neurons (Fig. 6G-I ) (punctum intensity: control ϭ 1.34 Ϯ 0.08; DHPG ϭ 1.07 Ϯ 0.08; p Ͼ 0.05; puncta colocalized with phalloidin: control ϭ 43.06 Ϯ 2.83%; DHPG ϭ 37.61 Ϯ 3.83%; p Ͼ 0.05).
To confirm the role of the N-cadherin/ ␤-catenin complex and its dependence on GluA2 in the culture system, we also examined DHPG-induced changes in ␤-catenin distribution in the dendritic spine. In both WT and GluA2 KO neurons, ␤-catenin immunostaining puncta were prominent and highly colocalized with phalloidin clusters, indicating that they were predominantly localized in the spines. We therefore analyzed both the density and intensity of the ␤-catenin puncta pre-and post-DHPG treatment. In WT neurons, DHPG treatment significantly reduced the mean intensity of ␤-catenin puncta (Fig. 7 A, B: basal ϭ 1.00 Ϯ 0.11; DHPG ϭ 0.73 Ϯ 0.04; p Ͻ 0.05), but this reduction was absent in GluA2 KO neurons (Fig.  7 A, B: basal ϭ 0.58 Ϯ 0.03; DHPG ϭ 0.50 Ϯ 0.04; p Ͼ 0.05). Interestingly, the punctum density of ␤-catenin staining was not significantly altered by DHPG treatment in either genotype (Fig. 7 A, (Fig. 7 A, B) . In agreement with the recording results, DHPG treatment resulted in a significant decrease in the amount of total surface and synaptic GluA1 in WT neurons (Fig. 7 D, Hippocampal mGluR-LTD deficit in GluA2 KO mice is functionally rescued by manipulating cofilin activity As a further proof that cofilin is responsible for the regulatory effect of GluA2/Ncadherin on mGluR-LTD, we performed functional rescue experiments. We reasoned that if GluA2/N-cadherin regulates mGluR-LTD through cofilin and the absence of mGluR-LTD in GluA2 KO was due to the lack of cofilin activation by mGluR, then the LTD deficit in the KO mice should be rescued or reduced by manipulating cofilin activity. We used a number of strategies to test this possibility. First, we included anti-LIMK1 antibodies or cofilin peptides in the recording pipette to enhance cofilin activity. LIMK1 is the major form of the LIMK family in the brain, and it plays the predominant role in inhibiting cofilin activity by phosphorylation (Meng et al., 2002; Bernard, 2007) . We expected that by inhibiting LIMK1 in GluA2 KO neurons, cofilin activity in these cells could be increased to a level sufficient for mGluR-LTD. As shown in Figure 8 A, while the anti-LIMK-1 antibody had no effect on basal synaptic responses, DHPG-induced LTD was fully restored (control IgG ϭ 121.04 Ϯ 7.35%; LIMK1 antibody ϭ Figure 7 . Requirement of GluA2 for DHPG-induced ␤-catenin changes in the dendritic spines. A, Cultured hippocampal neurons costained with the spine marker F-actin dye phalloidin (red), the dendritic marker MAP2 (blue), and anti-␤-catenin (green) showing DHPG-induced decrease in the mean puncta intensity of ␤-catenin in WT neurons, but not in GluA2 KO neurons. Arrows indicate ␤-catenin immunostaining puncta colocalized with phalloidin. Scale bar, 5 m. B, C, Summary data showing that the mean puncta intensity of ␤-catenin is significantly reduced by DHPG-treatment in WT but not in GluA2 KO neurons (B). Note the basal puncta intensity of ␤-catenin is significantly lower in GluA2 KO compared with WT neurons. The ␤-catenin puncta density is not significantly altered by the treatment in either genotype (C). D, Cultured hippocampal neurons costained for presynaptic marker synapsin I (green), the postsynaptic marker PSD95 (blue), and GluA1 (red), showing reduced synaptic GluA1 after DHPG treatment in WT neurons, but not in GluA2 KO neurons. Arrows indicate synaptic GluA1 puncta (i.e., surface GluA1 colocalized with both synapsin I and PSD95). Scale bar, 5 m. E, F, Summary data showing significantly reduced synaptic GluA1 (E), but not synapsin (F), after DHPG treatment in WT neurons, but not in GluA2 KO neurons. Note the basal synaptic GluA1 is also significantly lower in GluA2 KO than in WT neurons. n represents the number of neurons from three independent cultures. 66.32 Ϯ 3.78%; p Ͻ 0.001). The control IgG had no effect on either basal transmission or DHPG-induced LTD. Neither control IgG nor anti-LIMK1 antibodies had any effects on DHPG-induced LTD in WT animals ( Fig. 8 B: control IgG ϭ 75.96 Ϯ 4.12%; LIMK1 antibody ϭ 73.25 Ϯ 7.17%; p Ͼ 0.05). Similarly, the inclusion of the S3 peptide, but not the p-S3 peptide, also fully rescued DHPGinduced LTD (Fig. 8C: p-S3 ϭ 114 .77 Ϯ 6.62%; S3 ϭ 82.12 Ϯ 3.45%; p Ͻ 0.005). Second, we generated and analyzed double KO mice lacking both LIMK1 and GluA2. We have previously shown that cofilin activity is enhanced in the absence of LIMK1 (Meng et al., 2002) , and therefore we expected that the double KO mice would have a higher cofilin activity than GluA2 KO mice, enabling mGluR-LTD induction. As shown in Figure 8D , DHPG-induced LTD was also completely restored in the double KO mice (GluA2 KO ϭ 119.04 Ϯ 9.28%; GluA2/LIMK1 double KO ϭ 58.71 Ϯ 5.30%; p Ͻ 0.001). In fact, the magnitude of DHPG-induced LTD in GluA2/LIMK1 double KO mice was similar to those in LIMK1 KO and WT animals (Fig. 8D,F) and was still sensitive to the protein synthesis inhibitor cycloheximide (supplemental Fig. 4D , available at www.jneurosci.org as supplemental material). Finally, we tested whether the blockade of mGluR-LTD by acute disruption of GluA2/N-cadherin signaling in WT mice could also be rescued by cofilin. In previous experiments, we showed that INP treatment blocked DHPG-induced LTD (Fig. 3) , and if this effect was due to perturbed cofilin function, as suggested by the biochemical data (Fig. 5) , then this DHPG-induced LTD deficit could also be rescued by manipulating cofilin. As shown in Figure 8E , both peptide S3 and anti-LIMK1 antibodies, but not peptide p-S3 restored DHPG-induced LTD in INPtreated slices (pS3 ϭ 102.68 Ϯ 2.19%; S3 ϭ 74.16 Ϯ 3.89%; p Ͻ 005 compared with pS3; anti-LIMK1 ϭ 69.40 Ϯ 2.39%; p Ͻ 0.005 compared with pS3), indicating that the effect of N-cadherin is mediated by cofilin. These rescue experiments together provided compelling functional evidence that the mGluR-LTD deficit by either genetic deletion of GluA2 or acute disruption of N-cadherin signaling is due to the lack of cofilin activation by mGluR, and together with above biochemical data indicating that cofilin is the key downstream target of GluA2/N-cadherin and that GluA2/N-cadherin controls mGluR-LTD via regulating cofilin.
Discussion
Regulated protein interactions play a critical role in AMPAR properties and expression of long-lasting synaptic plasticity. However, despite the extensive studies, little is known about the significance and underlying mechanisms of the protein interactions involving the NTD of AMPARs. In this study, we demonstrate that the GluA2 NTD/N-cadherin interaction regulates hippocampal mGluR-LTD through a previously unknown actin-based mechanism that is distinct from those used by the other domains of the subunit. .TheDHPG-induced LTD was absent in the GluA2 KO mice, which were derived from the same breeding used for generating the double KO mice, and therefore they were similar in genetic background. E, Whole-cell recordings showing restoration of DHPG-induced LTD in INP-treated neurons (50 M,30min)byinfusingS3peptide(200M)oranti-LIMK-1(10g/ml),butnotbypeptidep-S3(200M).F,Summarydatashowingthe magnitudesofDHPG-inducedLTDofvariousgenotypes/manipulationsusedintherescueexperimentsbymanipulatingcofilin.TheDHPGinducedLTDinLIMK1antibody-treated,peptideS3-treated,andGluA2/LIMK1doubleKOneuronswassimilartothatoftheWTneuronsbut was significantly different from that of untreated GluA2 KO neurons or those treated with peptide p-S3 or control IgG. DKO, GluA2/LIMK1 doubleKO;CtrlIgG,GluA2KOinfusedwithcontrolIgG;LIMKantibody,GluA2KOneuronsinfusedwithanti-LIMK1antibodies;S3,GluA2KO neurons infused with peptide S3; p-S3, GluA2 KO neurons infused with peptide p-S3.
mental Fig. 4C , available at www.jneurosci.org as supplemental material). Third, mGluR-LTD deficit in GluA2 KO mice is fully rescued by increasing cofilin activity; therefore, the absence of mGluR-LTD in GluA2 KO mice is not likely due to the absence of GluA2 per se (e.g., GluR2 protein synthesis or its direct involvement in AMPAR internalization), but rather is due to the lack of GluA2/N-cadherindependent, protein synthesis-independent cofilin signaling process. Because mGluR-LTD in GluA2/LIMK-1 double KO mice still requires new protein synthesis (supplemental Fig. 4D , available at www.jneurosci.org as supplemental material), activation of cofilin alone is thus not sufficient for mGluR-LTD. This is also consistent with the result that application of INP peptide, although being capable of activating cofilin, is not sufficient to induce LTD (supplemental Fig. 2B , available at www.jneurosci.org as supplemental material). However, we cannot rule out the possibility that GluA2/ N-cadherin-dependent cofilin signaling and protein synthesis may represent sequential but different aspects of LTD, with the former being important for the induction and the latter being important for a consolidation/expression mechanism. Further experiments will be needed to address these interesting questions.
Long-lasting synaptic plasticity, including mGluR-LTD, is usually associated with structural changes at the synapse (Vanderklish and Edelman, 2002; Alvarez and Sabatini, 2007; Bourne and Harris, 2008) . However, how these two forms of plasticity are coordinated is poorly understood. Given the transsynaptic nature of N-cadherin molecules and their ability to regulate the actin cytoskeleton, our demonstration that the GluA2/ N-cadherin interaction is critical for mGluR-LTD and associated spine plasticity has important implications in this respect. By placing N-cadherin under the direct control of GluA2, postsynaptic responses mediated by AMPARs are coupled not only to the postsynaptic structure, but also to the presynaptic element, to achieve structural and functional coupling during long-lasting synaptic plasticity.
In summary, we have identified a previously unknown N-cadherin-dependent, cofilin-mediated signaling process by which the NTD of GluA2 regulates mGluR-LTD in the hippocampus (for a summary model, see supplemental Fig. 6 , available at www.jneurosci.org as supplemental material). Further analysis of this pathway may provide a valuable venue for understanding molecular mechanisms and functional/structural coupling underlying long-lasting synaptic plasticity in the central synapse.
